Haleon plc HLN
At closeNov 6, 2026, 4:00 PM EST
After hours · Nov 6, 4:00 PM ET
- YTD
- -9.59%
- 1 year
- -2.87%
- Market cap
- 40.17B
- Revenue (ttm)
- 11.15B
- Profit margin
- 14.55%
- EPS (ttm)
- 0.49
- Shares out
- 4.40B
- P/E ratio
- 18.65
- Forward P/E
- 15.11
- Dividend
- 0.20 (2.16%)
- Ex-dividend date
- Aug 13, 2026
- YTD return
- -9.59%
- 1-year return
- -2.87%
- Volume
- 18.68M
- Avg volume
- 17.44M
- Open
- 8.91
- Previous close
- 9.15
- Day's range
- 8.88 – 9.15
- 52-week range
- 8.57 – 11.27
- Beta
- 0.29
- Analysts
- Buy
- Price target
- 10.40 (+13.8%)
- Earnings date
- Mar 4, 2027
1M +0.12 (+1.33%)
Key statistics
- Enterprise value
- 48.13B
- PEG ratio
- 2.07
- Price / sales
- 3.60
- Price / book
- 1.85
- Dividend yield
- 2.16%
- Payout ratio
- 40.08%
- Revenue growth
- 2.20%
- Free cash flow
- 1.80B
- Total cash
- 826.00M
- Total debt
- 8.25B
- Return on equity
- 10.09%
- Short % of float
- 0.42%
- 50-day average
- 9.45
- 200-day average
- 9.75
Analyst view
Consensus: buy
- Target (low)
- 9.79
- Target (mean)
- 10.40
- Target (high)
- 11.40
- Strong buy3
- Buy0
- Hold2
- Sell0
- Strong sell0
Next earnings
Mar 4, 2027
Expected Mar 4, 2027. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 4, 2027 | Dec 30, 2026 | 0.2793 | — | — | — |
| Jul 30, 2026 | Jun 30, 2026 | 0.2669 | 0.2766 | +0.01 | +3.63% |
| Feb 25, 2026 | Dec 31, 2025 | 0.2512 | 0.2597 | +0.01 | +3.38% |
| Jul 31, 2025 | Jun 30, 2025 | 0.2449 | 0.2435 | 0.00 | -0.57% |
| Feb 27, 2025 | Dec 31, 2024 | 0.2156 | 0.2269 | +0.01 | +5.24% |
| Oct 31, 2024 | Jun 30, 2024 | 0.11 | 0.2303 | +0.12 | +109.36% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 23, 2026 | Barclays | up | Equal-Weight | Overweight |
| Sep 16, 2025 | Barclays | down | Overweight | Equal-Weight |
| Sep 20, 2024 | Morgan Stanley | main | Overweight | Overweight |
| Mar 26, 2024 | Argus Research | main | Buy | Buy |
| Nov 1, 2023 | Morgan Stanley | init | — | Overweight |
| Apr 6, 2023 | Argus Research | up | Hold | Buy |
About Haleon plc
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc has a collaboration agreement with Microsoft to scale digital, data and AI capabilities across the business and accelerate delivery of its global win as one strategy. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United Kingdom
- Website
- haleon.com
News
Haleon Adjusts FY26 Organic Revenue Growth To ~2.5%, High-Single-Digit Adjusted Operating Profit Growth At Constant Currency, Net Interest Of ~£255 Million, Incorporating China Centrum OTC Product Classification Changes And Accelerated Brazil Go-To-Market Model Rollout 
Consumer Healthcare Giant Haleon Plunges to 52-Week Low - Haleon Commences £500 Million Share Buyback Program
12 Health Care Stocks Moving In Thursday's Pre-Market Session 
ServiceNow Posts Downbeat Q3 Earnings, Joins Sprouts Farmers Market, Alphabet And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session - Haleon CEO Says 70% Of Cold And Flu Business Is Outside U.S.; Season Start Not Yet Seen In International Markets, Slightly Down To Date; China Centrum OTC Issue Not Expected To Have Solution In 2027; Working To Mitigate By Making Portfolio Changes In China; Doesn't Believe Company Has Pricing Issue, We Have Pricing Elasticities
Sensodyne Maker Haleon Leverages Eye-Level Shelf Placement To Outpace Rivals-Report 
'Haleon Says It Negotiated Better Walmart, Target Shelf Space Via U.S. Price Deals; Haleon Says Improved Shelf Positions Are Driving U.S. Market Share' - Reuters Exclusive 
Haleon H1 Adj. EPS $0.14 Up From $0.12 YoY, Sales $7.533B Beat $3.600B Estimate 
Consumer Tech (June 29-July 2): Microsoft Announces Layoffs, Meta & Google Sued In Several States & More
Your note
Sign in to keep a note on HLN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BlackRock, Inc. | — | Increase | Jan 14, 2025 | 3,148,569 |
| McNamara (Brian) | — | Bought | Sep 22, 2026 | 453,250 |
| Paley (Lisa) | — | Bought | Mar 13, 2025 | 309,822 |
| Pfizer Inc. | — | Decrease | Feb 23, 2025 | 0 |
| Wellington Management Group LLP | — | Decrease | Sep 22, 2025 | 13,087,525 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Dodge & Cox Inc. | 3.40% | 149,934,507 | 1.37B | Jun 29, 2026 |
| FMR, LLC | 2.75% | 120,991,250 | 1.11B | Jun 29, 2026 |
| ClearBridge Investments, LLC | 0.73% | 32,342,126 | 295.45M | Jun 29, 2026 |
| Morgan Stanley | 0.44% | 19,461,762 | 177.78M | Jun 29, 2026 |
| Mondrian Investment Partners Ltd | 0.40% | 17,637,434 | 161.12M | Sep 29, 2026 |
| Harris Associates L.P. | 0.38% | 16,833,252 | 153.77M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 2.44% | 107,251,461 | 979.74M | Jun 29, 2026 |
| Fidelity Hastings Street Trust-Fidelity Series Large Cap Stock Fund | 0.47% | 20,635,036 | 188.50M | Sep 29, 2026 |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 0.35% | 15,408,559 | 140.76M | Sep 29, 2026 |
| HARRIS ASSOCIATES INVESTMENT TRUST-Oakmark International Fund | 0.30% | 13,300,500 | 121.50M | Jun 29, 2026 |
| Dodge & Cox Funds-Dodge & Cox Balanced Fund | 0.27% | 11,685,813 | 106.75M | Jun 29, 2026 |
| Fidelity Securities Fund-Fidelity Growth & Income Portfolio | 0.27% | 12,085,320 | 110.40M | Sep 29, 2026 |